Queen Mary University of London at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

Queen Mary University of London takes part in 8 sessions at FoG London 2027 in London, its home city. Its sessions centre on rare disease diagnosis and variant interpretation, including AI agents and proteomics for patients still undiagnosed after genome sequencing. Other topics include a human DNA methylation atlas, pharmacogenomics in healthcare, and spotting bias and data leakage in AI models.

OrganizationFoG London 2027 Attendance
Universities & institutes
London research university with genomic medicine, computational biology, clinical pharmacology and population health research.
Talk
Wed Jan 27
11:30–12:00
AI Agents for Rare Disease Diagnosis: Accelerating Variant Interpretation in Clinical Genomics
How AI agents and large language models can speed up interpreting genetic variants for rare disease diagnosis within NHS genomic services.
Talk
Wed Jan 27
11:30–12:00
Pharmacogenomics in Healthcare
How health systems could adopt pharmacogenomics, testing genes to guide prescribing, and whether to test in advance or only when needed.
Talk
Wed Jan 27
11:30–12:00
Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing
How unusually low blood protein levels could help diagnose rare disease patients left undiagnosed after whole-genome sequencing, and flag new disease genes.
Talk
Wed Jan 27
11:30–13:00
Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes
Genome Dome · with University of Edinburgh, University of Surrey, The Alan Turing Institute +2 more
AI in drug discovery & diagnostics
Talk
Wed Jan 27
15:30–16:00
Telomere Biology Disorders: Insights into Early-Life Programming and Lifelong Disease Risk
How rare congenital disorders show why telomeres, the protective caps on chromosome ends, matter early in life and shape lifelong disease risk.
Talk
Thu Jan 28
14:10–14:40
From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care
How population genomic testing can find people at higher risk of women's cancers and guide targeted screening and prevention.
Talk
Thu Jan 28
15:10–15:40
A Human DNA Methylation Atlas for Epigenomic Interpretation
How an atlas of DNA methylation marks across healthy human cell types helps interpret epigenetic data and cell-free DNA in blood.
Talk
Thu Jan 28
16:40–17:10
Rethinking Monogenic DIsease in the Era of Population Genomics
How population-scale genome data and new ways to detect repeated DNA sequences are changing how single-gene diseases are understood.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Queen Mary University of London

Tell us what you sell and we’ll find the people at Queen Mary University of London most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction